Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2024
Toward Evidence-based Recommendations for Laboratory Monitoring for Adolescents and Adults on Antiretroviral TherapyWilliam J Burman, Kellie L Hawkins
Idcases|April 1, 2020
Intramedullary spinal cord lesions in an immunocompromised host due to Mycobacterium haemophilumShelley Kon, Carlos Franco-Paredes, Kellie L Hawkins
Journal of Investigative Medicine High Impact Case Reports|February 17, 2017
Resolution of Q Fever-Associated Cryoglobulinemia With Anti-CD20 Monoclonal Antibody TreatmentKellie L Hawkins, Edward N Janoff, Robert W Janson
Case Reports in Infectious Diseases|August 16, 2017
A Case of Fulminant Meningococcemia: It Is All in the ComplementKellie L Hawkins, Mariah Hoffman, Sonia Okuyama, et al.
AIDS (London, England)|May 5, 2017
Geriatric syndromes: new frontiers in HIV and sarcopeniaKellie L Hawkins, Todd T Brown, Joseph B Margolick, et al.
Open Forum Infectious Diseases|November 5, 2021
Multiple-Dose Dalbavancin Regimens as the Predominant Treatment of Deep-Seated or Endovascular Infections: A Scoping ReviewMargaret M Cooper, Candice R Preslaski, Katherine C Shihadeh, et al.
Journal of the International Association of Providers of AIDS Care|June 9, 2026
Benefits of Small-Group Education and Community Partner Networking for Reengagement and Retention in Clinical Services Among People With HIV in the United StatesGena Dolson, Amanda Glazar, Kellie L Hawkins, et al.
Antiviral Therapy|September 21, 2019
Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individualsKellie L Hawkins, Brian T Montague, Sarah E Rowan, et al.
AIDS Care|October 6, 2025
The "ART review": formalizing a process to document complex HIV treatment histories and to support treatment optimizationKellie L Hawkins, Leila S Hojat, Carrie Hicks, et al.
HIV Research & Clinical Practice|June 4, 2024
Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIVArianna E Kousari, Melissa P Wilson, Kellie L Hawkins, et al.
Pageof 2